These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18796447)

  • 21. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.
    Gurbel PA; Bliden KP; Zaman KA; Yoho JA; Hayes KM; Tantry US
    Circulation; 2005 Mar; 111(9):1153-9. PubMed ID: 15738352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter regarding article by Markus et al, "Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic cardiac stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial".
    Imray CH; Higman DJ; Marshall C
    Circulation; 2005 Nov; 112(20):e325; author reply e325-6. PubMed ID: 16286597
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter regarding article by Markus et al, "Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic cardiac stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial".
    Cohen SN
    Circulation; 2005 Nov; 112(20):e325; author reply e325-6. PubMed ID: 16299891
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.
    Dai H; Chen J; Tao Q; Zhu J; Zhang F; Zheng L; Qiu Y
    Postgrad Med J; 2003 Sep; 79(935):522-6. PubMed ID: 13679549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserved thrombin-inducible platelet activation in thienopyridine-treated patients.
    Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S
    Eur J Clin Invest; 2013 Jul; 43(7):689-97. PubMed ID: 23611368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of different duration of clopidogrel pretreatment on platelet activation in patients undergoing stenting].
    Liu F; Liu JC; Wang LJ; Li J; Xu XD; Liu Y; Huang YN; Wang DM
    Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):411-4. PubMed ID: 19595223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Outpatient primary stent-angioplasty in symptomatic internal carotid artery stenoses].
    Andresen R; Roth M; Brinckmann W
    Zentralbl Chir; 2003 Sep; 128(9):703-8. PubMed ID: 14533036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
    Ma B; Hang L; Chen G; Du Y
    West Indian Med J; 2013 Feb; 62(2):135-9. PubMed ID: 24564063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
    Markus HS; Droste DW; Kaps M; Larrue V; Lees KR; Siebler M; Ringelstein EB
    Circulation; 2005 May; 111(17):2233-40. PubMed ID: 15851601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis.
    Gurbel PA; Samara WM; Bliden KP
    Platelets; 2004 Mar; 15(2):95-9. PubMed ID: 15154601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of embolization during protected renal artery angioplasty and stenting: Role of antiplatelet therapy.
    Kanjwal K; Cooper CJ; Virmani R; Haller S; Shapiro JI; Burket MW; Steffes M; Brewster P; Zhang H; Colyer WR
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):16-23. PubMed ID: 20209644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embolic protection and platelet inhibition during renal artery stenting.
    Cooper CJ; Haller ST; Colyer W; Steffes M; Burket MW; Thomas WJ; Safian R; Reddy B; Brewster P; Ankenbrandt MA; Virmani R; Dippel E; Rocha-Singh K; Murphy TP; Kennedy DJ; Shapiro JI; D'Agostino RD; Pencina MJ; Khuder S
    Circulation; 2008 May; 117(21):2752-60. PubMed ID: 18490527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation.
    Rupprecht HJ; Darius H; Borkowski U; Voigtländer T; Nowak B; Genth S; Meyer J
    Circulation; 1998 Mar; 97(11):1046-52. PubMed ID: 9531251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet effect of ticlopidine after coronary stenting.
    Neumann FJ; Gawaz M; Dickfeld T; Wehinger A; Walter H; Blasini R; Schomig A
    J Am Coll Cardiol; 1997 Jun; 29(7):1515-9. PubMed ID: 9180113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy.
    Nishi H; Nakahara I; Matsumoto S; Hashimoto T; Ohta T; Sadamasa N; Ishibashi R; Gomi M; Saka M; Miyata H; Watanabe S; Okata T; Sonoda K; Kouge J; Ishii A; Nagata I; Kira J
    J Neurointerv Surg; 2016 Sep; 8(9):949-53. PubMed ID: 26297788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility trial of carotid stenting with and without an embolus protection device.
    Ouriel K; Wholey MH; Fayad P; Katzen BT; Whitlow P; Frentzko M; Kuntz RE; Wechsler L; Hopkins N; Satler L; Mishkel G; Yadav JS
    J Endovasc Ther; 2005 Oct; 12(5):525-37. PubMed ID: 16212452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Hernández-Antolín R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Macaya C
    J Invasive Cardiol; 2004 Jun; 16(6):325-9. PubMed ID: 15156004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.